Meet the Management Team
Buel "Dan" Rodgers, PhD
Founder & CEO, Muscle developmental biologist
Jade Brown, MBA
Business Development Director
Chris Novashinski
Regulatory Affairs Director, Co-Founder & COO RareMoon
Brian O'Rourke, PhD
Science Advisory Board - Cardiac Translational Medicine
Alexandra McPherron, PhD
CSO, Muscle molecular biologist
Joseph Rininger, PhD
CMC Director, Managing Director SIA LBG
William Mann, PhD/MBA
Chair, Science Advisory Board
- Corporate Relations
- Drug Development
Jeffrey S. Chamberlain, PhD
Science Advisory Board - Neuromuscular Disease Gene Therapy
Gary Carswell, CPA
CFO, Founder & President Carswell & Associates
Sarah K. Herring, PhD
Preclinical Director,
Manager SIA LBG
Thomas E. Lloyd, MD/PhD
Clinical Director, Science Advisory Board - Inclusion Body Myositis
Paul Gregorevic, PhD
Science Advisory Board - Muscle Gene Therapy & Physiology
RareMoon Regulatory Consultants
Regulatory services are contracted from RareMoon, leaders in gene therapy and rare disease consulting. This local agency provides non-clinical, clinical and statistical expertise to Aavogen and other clients globally.
Legal Representation
Frances Mosley
As a Partner at DLA Piper, Frances focuses her practice on a wide range of transactional and corporate matters, where she represents emerging growth companies and venture investors in general corporate matters, Board governance, securities law compliance, venture capital and debt financings, mergers and acquisitions. She is assisted by James McGraw, an Associate with expertise in strategic transactions across the life sciences.
Lisa Hillman
As a Partner at Lathrop GPM and over 20 years' experience in intellectual property lay, Lisa focuses on strategic patent counseling both domestically and internationally, concentrating on the life sciences industry. She advises start-ups, universities and global pharmaceutical companies with patent prosecution, portfolio management and validity opinions, due diligence and freedom-to-operate and infringement opinions.
